Product Categories
| Country: | China |
|---|---|
| Tel: | 021-61350663 |
| Mobile: | 13052117465 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Ceapin-A7 | C20H12F6N4O3 | 2323027-38-7 | Details |
| GLX351322 | C21H25N3O5S | 835598-94-2 | Details |
| CHIR-98014 | C20H17Cl2N9O2 | 252935-94-7 | Details |
| metipranolol | C17H27NO4 | 22664-55-7 | Details |
| ERK5-IN-2 | C17H11BrFN3O2 | 1888305-96-1 | Details |
| SJA710-6 | C22H20BrFN4 | 1397255-09-2 | Details |
| SGI 1027 | C27H23N7O | 1020149-73-8 | Details |
| WH-4-023 | C32H36N6O4 | 837422-57-8 | Details |
| SI-60 | C18H17F6OSSb | 133152-67-7 | Details |
| AK120765 | C19H15ClN4O2 | 955272-06-7 | Details |
| PEO-IAA | C18H15NO3 | 6266-66-6 | Details |
| ZM223 | C23H17F3N4O2S2 | 2031177-48-5 | Details |
| CK869 | C17H16BrNO3S | 388592-44-7 | Details |
| XMD-17-51 | C21H24N8O | 1628614-50-5 | Details |
| DMU2139 | C19H15NO2 | 104890-70-2 | Details |
| XMD 8-92 | C26H30N6O3 | 1234480-50-2 | Details |
| AF64394 | C21H20ClN5O | 1637300-25-4 | Details |
| Seclidemstat | C20H23ClN4O4S | 1423715-37-0 | Details |
| DMU2105 | C18H13NO | 1031063-36-1 | Details |
| AC5216 | C23H23N5O2 | 226954-04-7 | Details |
| IDF-11774 | C23H32N2O2 | 1429054-28-3 | Details |
| SBI-115 | C14H13ClN2O4S | 882366-16-7 | Details |
| (+/-)-BAY K 8644 | C16H15F3N2O4 | 71145-03-4 | Details |
| TRi-1 | C12H9ClN2O5S | 246020-68-6 | Details |
| PF-4878691 | C17H23N5O2S | 532959-63-0 | Details |
| Aripiprazole Dimer Impurity | C48H56Cl4N6O4 | 1797986-18-5 | Details |
| JAK3-IN-6 | C19H18N4O3 | 1443235-95-7 | Details |
| Tegobuvir | C25H14F7N5 | 1000787-75-6 | Details |
| yGsy2p-IN-1 | C16H11F3N2O4 | 2415003-97-1 | Details |
| 4-(Chloromethyl)-2,6-dimethylpyridine | C8H10ClN | 120739-87-9 | Details |
| Voxtalisib (XL765, SAR245409) | C13H14N6O | 934493-76-2 | Details |
| ON1231320 | C22H15F2N5O3S | 1312471-39-8 | Details |
| Lersivirine(UK 453061) | C17H18N4O2 | 473921-12-9 | Details |
| ACY-775 | C17H19FN4O2 | 1375466-18-4 | Details |
| MRT68921 HCI | C25H35ClN6O | 2070014-87-6 | Details |
| Elacridar | C34H33N3O5 | 143664-11-3 | Details |
| WAY-181187(SAX-187) | C15H13ClN4O2S2 | 554403-49-5 | Details |
| Amifloxacin | C16H19FN4O3 | 86393-37-5 | Details |
| Compound A | C47H63ClN4O14S | 1665301-36-9 | Details |
| DM1-SMe | C36H50ClN3O10S2 | 138148-68-2 | Details |
| 4-ACRYLAMIDOBENZO-18-CROWN-6, 98 | C19H27NO7 | 68865-32-7 | Details |
| 5-chloro-2,3-dihydro-benzofuran-3-ol | C8H7ClO2 | 5590-44-3 | Details |
| Lys-SMCC-DM1 | C53H75ClN6O15S | 1281816-04-3 | Details |
| PLX4032 (Vemurafenib) | C23H18ClF2N3O3S | 918504-65-1 | Details |
| J-14 | C28H25ClN4O2S | 1043854-13-2 | Details |
| PF-573228 | C22H20F3N5O3S | 869288-64-2 | Details |
| Pexmetinib (ARRY-614) | C31H33FN6O3 | 945614-12-0 | Details |
| CWHM-12 | C26H32BrN5O6 | 1564286-55-0 | Details |
| Voxelotor(GBT440, GTx011) | C19H19N3O3 | 1446321-46-5 | Details |
| AMG-3969 | C21H20F6N4O3S | 1361224-53-4 | Details |
| Defactinib hydrochloride | C20H22ClF3N8O3S | 1073160-26-5 | Details |
| GNE-3511 | C23H26F2N6O | 1496581-76-0 | Details |
| AC 55541 | C25H20BrN5O3 | 916170-19-9 | Details |
| MK-4101 | C24H24F5N5O | 935273-79-3 | Details |
| BAY-876 | C24H16F4N6O2 | 1799753-84-6 | Details |
| GSK189254A | C21H25N3O2 | 720690-73-3 | Details |
| PFI-3 | C19H19N3O2 | 1819363-80-8 | Details |
| CHIR-090 | C24H27N3O5 | 728865-23-4 | Details |
| MS023 | C17H25N3O | 1831110-54-3 | Details |
| Vipadenant(BIIB-014) | C16H15N7O | 442908-10-3 | Details |
| SH-4-54 | C29H27F5N2O5S | 1456632-40-8 | Details |
| SUN11602 | C26H37N5O2 | 704869-38-5 | Details |
| NVS-PAK1-1 | C23H25ClF3N5O | 1783816-74-9 | Details |
| PF03274167 | C19H19ClFN5O3 | 900510-03-4 | Details |
| Motolimod (VTX-2337) | C28H34N4O2 | 926927-61-9 | Details |
| BDA-366 | C24H29N3O4 | 1909226-00-1 | Details |
| Grapiprant | C26H29N5O3S | 415903-37-6 | Details |
| ETP-46321 | C20H27N9O3S | 1252594-99-2 | Details |
| CNV 1014802 hydrochloride | C18H20ClFN2O2 | 934240-31-0 | Details |
| STK16-IN-1 | C17H12FN3O | 1223001-53-3 | Details |
| Fatostatin A Hydrobromide | C18H19BrN2S | 298197-04-3 | Details |
| CP-609754 | C29H22ClN3O2 | 1190094-64-4 | Details |
| ABT-639 | C20H20ClF2N3O3S | 1235560-28-7 | Details |
| GDC-0084 | C18H22N8O2 | 1382979-44-3 | Details |
| UNC1215 | C32H43N5O2 | 1415800-43-9 | Details |
| CPI-637 | C22H22N6O | 1884712-47-3 | Details |
| EPZ015866,GSK3203591 | C22H28N4O2 | 1616391-87-7 | Details |
| Blu-263 | Details |
| TRPM8 antagonist 2 | C26H26N2O2 | 259674-19-6 | Details |
| 5-CHLORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINE | C8H8ClNO | 769-21-1 | Details |
| Datelliptium chloride | 105118-14-7 | Details |
| UK-371804 | C14H16ClN5O4S | 256477-09-5 | Details |
| MKC3946 | C21H20N2O3S | 1093119-54-0 | Details |
| Acebilustat | C29H27N3O4 | 943764-99-6 | Details |
| Onatasertib(CC 223,ATG-008) | C21H27N5O3 | 1228013-30-6 | Details |
| LACS-13909 | C17H18Cl2N6 | 2160546-07-4 | Details |
| SHP099 | C16H19Cl2N5 | 1801747-42-1 | Details |
| Lanraplenib (GS-9876) | C23H25N9O | 1800046-95-0 | Details |
| CB-103 | C15H18N2O | 218457-67-1 | Details |
| GSK046 | C23H27FN2O4 | 2474876-09-8 | Details |
| Lasmiditan | C19H18F3N3O2 | 439239-90-4 | Details |
| Lasmiditan hydrochloride | C19H19ClF3N3O2 | 613677-28-4 | Details |
| MRT 68921 dihydrochloride | C25H35ClN6O | 2080306-21-2 | Details |
| IDO-IN-7(Navoximod) | C18H21FN2O2 | 1402837-78-8 | Details |
| Dasotraline hydrochloride | C16H15Cl2N.ClH | 675126-08-6 | Details |
| IM156 | C13H16F3N5O | 1422365-93-2 | Details |
| Verinurad | C20H16N2O2S | 1352792-74-5 | Details |
| HG-10-102-01 | C17H20ClN5O3 | 1351758-81-0 | Details |
| CDKI-73 | C15H15FN6O2S2 | 1421693-22-2 | Details |
| DGY-06-116 | C32H33ClN8O2 | 2556836-50-9 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 | ||||